Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triolex Phase II in T2DM
NCT00694057Phase 2Completed
- Sponsor
- Harbor Therapeutics, Inc.
- Start
- Jun 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bezisterim in type 2 diabetes mellitus (T2DM), sponsored by Harbor Therapeutics, Inc.. Started Jun 2008; status: completed.
02
Drugs
bezisterim
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00694057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00694057.